Deletion of p16 and p15 genes in brain tumors

J. Jen, Nickolas Papadopoulos, Kenneth W Kinzler, Bert Vogelstein, N. Papadopoulos, S. Markowitz, J. K V Willson, K. W. Kinzler, B. Vogelstein

Research output: Contribution to journalArticle


We have used molecular genetic methods to examine the status of cell cycle-inhibitory genes in human brain tumors. We found that p16 and a neighboring gene, p15, were often homozygously deleted in glioblastoma multiformes but not in medulloblastomas or ependymomas. The deletions occurred in both primary tumors and their derived xenografts, but no intragenic mutations in either of the two genes were found. The p15 gene was expressed in a more widespread pattern in normal tissues than p16, but the products of both genes had similar capacities to bind to cyclin D-dependent kinases 4 and 6. These data suggest that the target of deletion in glioblastoma multiforme includes both p15 and p16 genes. The reason that homozygous deletions, rather than intragenic mutations, are so common in these tumors may be that deletion is a more efficient mechanism for simultaneous inactivation of both genes.

Original languageEnglish (US)
Pages (from-to)6353-6358
Number of pages6
JournalCancer Research
Issue number24
StatePublished - 1994


ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Jen, J., Papadopoulos, N., Kinzler, K. W., Vogelstein, B., Papadopoulos, N., Markowitz, S., Willson, J. K. V., Kinzler, K. W., & Vogelstein, B. (1994). Deletion of p16 and p15 genes in brain tumors. Cancer Research, 54(24), 6353-6358.